Opexa Therapeutics Inc (NASDAQ:OPXA)

Data as of 3:59pm ET
 +0.038 / +3.98%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Opexa Therapeutics, Inc. is a biopharmaceutical company developing personalized immunotherapy with the potential to treat major illnesses, including multiple sclerosis. This therapy is based on T-cell technology. The company's therapy candidate, Tcelna, is a personalized T-cell immunotherapy for the treatment of secondary progressive multiple sclerosis. The company was founded in 2004 and is headquartered in The Woodlands, TX.

Contact Information

Opexa Therapeutics, Inc.
2635 Technology Forest Boulevard
The Woodlands Texas 77381
P:(281) 775-0600
Investor Relations:



Individual stakeholders3.97%
Mutual fund holders2.56%
Other institutional1.82%

Top Executives

Neil K. WarmaPresident, Chief Executive Officer & Director
Donna R. RillChief Development Officer & SVP-Operations
Karthik RadhakrishnanChief Financial Officer
Dawn McGuireChief Medical Officer
Donald HealeyChief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.